Your vaccine questions deserve real answers | Kizzmekia Corbett | Your Body on Tech

Episode Summary

Executive Summary: Kizmikia Corbett argues that vaccine science succeeded technically during COVID-19, but scientists failed to communicate with and listen to the public. Through a personal story about dating a vaccine skeptic, she reframes skepticism as “vaccine inquisitiveness” and calls for more humane, nuanced dialogue to rebuild trust, improve uptake, and prepare for future pandemics.

Main Topics: From vaccine development to public trust: Corbett contrasts the rapid creation of the Moderna COVID vaccine with the much harder task of earning public confidence in it, arguing that scientific success alone is insufficient without trust-building. Vaccine inquisitiveness vs. hesitancy: She proposes replacing stigmatizing labels with a more welcoming framing that treats questions and concerns as legitimate curiosity rather than anti-science behavior. Communication mistakes during COVID-19: Corbett acknowledges that scientists overstated early claims, under-addressed possible injuries, and failed to explain uncertainty and changing evidence clearly in real time. Listening as a scientific skill: Her first-date story becomes a lesson that listening to people’s doubts is as important as explaining the data, and that communication must be two-way. Historical mistrust and inequity: She connects vaccine skepticism to real historical harms, especially in Black communities, and argues that trust must be rebuilt with empathy and social awareness. Future pandemics and preparedness: Corbett emphasizes that another pandemic is likely and says society needs both better vaccine platforms and better public communication systems before the next outbreak.

Key Arguments: Rapid vaccine development was a major scientific achievement, but it did not automatically translate into public acceptance or trust. Scientists, including Corbett herself, made communication errors by oversimplifying efficacy, not emphasizing uncertainty, and dismissing rare adverse-event concerns. Many people labeled “hesitant” are not anti-vax or anti-science; they are uncertain, skeptical, or carrying valid questions that deserve respect. Words shape perception: calling someone “inquisitive” encourages engagement, while “hesitant” can feel judgmental and closed off. Historical abuses and inequities have created understandable mistrust in some communities, so rebuilding trust requires empathy rather than scolding. Anecdotes and lived experience matter in public health discussions because that is how many people evaluate risk and make decisions. Scientists should communicate earlier and more openly about ongoing research, not only when a crisis emerges, to reduce surprise-driven skepticism. Pandemic preparedness requires both stronger vaccine technology and a communication culture that treats the public as partners, not just recipients.

Data Points: Time to vaccine trial: 66 days - The Moderna mRNA-1273/SpikeVax vaccine entered Phase I clinical trial in a record-breaking timeframe during COVID-19. Original development goal: 100 days - Corbett’s team set a goal to reach Phase I in 100 days but beat it significantly. Reported effectiveness: 94% - By the end of 2020, the vaccine was determined to be highly effective against disease. Vaccine hesitancy level: 20% - Corbett cites WHO-style vaccine hesitancy as a major barrier despite the vaccine’s success. Global health threat ranking: Top 10 - She notes vaccine hesitancy was already considered among the top global health threats before the pandemic. Viral families affecting humans: 23 - Corbett uses this figure to argue that future outbreaks are inevitable. People sickened in early Wuhan report: 27 - She references the first mysterious-virus report from Wuhan that helped trigger her team’s rapid response. Age when first exposed to lab work: 16 - Corbett says early lab exposure helped shape her eventual path into vaccine science. Year of first date anecdote: 2018 - Her formative conversation with a vaccine-skeptical date happened in summer 2018.

Pivotal Quotes: "We were too busy publishing our data in world-renowned journals, kind of talking to ourselves." — Kizmikia Corbett: Corbett reflects on how vaccinologists failed to engage skeptical or undecided audiences before and during COVID-19. "I use that phrase, vaccine inquisitive, to humanize the idea that it is okay to have questions and concerns around anything medically that could be happening to you." — Kizmikia Corbett: She explains the rationale for replacing “hesitant” with a more empathetic term. "It’s not a question of whether there will be another pandemic, it’s a matter of when." — Kizmikia Corbett: Corbett underscores the inevitability of future outbreaks and the need for preparedness.

Implications: Listeners should expect future outbreaks and more vaccine debate, so trust-building, empathy, and clearer public communication are as important as scientific innovation. For health institutions, engagement must start before crises, not after.